They constructed a signature of six such lncRNAs (AC124798.1, AL031985.3, AC103760.1, NRAV, WAC-AS1, and AC022613.1), which can predict HCC prognosis and guide clinical HCC management, including immunotherapy [81]. The gene discussed is NRAV; the disease is hepatocellular carcinoma.